• Molecular NameEdrophonium
  • SynonymEDR; Edrophone Chloride; Edrophonium Chloride; Edrophonium Ion; Edrophonum
  • Weight166.244
  • Drugbank_IDDB01010
  • ACS_NO116-38-1
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-2.3
  • pkaN/A
  • LogD (pH=7, predicted)-2.34
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.22
  • LogSw (predicted, AB/LogsW2.0)256.44
  • Sw (mg/ml) (predicted, ACD/Labs)276.55
  • No.of HBond Donors1
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds2
  • TPSA20.23
  • StatusFDA approved
  • AdministrationIntramuscular
  • PharmacologyA readily reversible acetylcholinesterase inhibitor. It prevents breakdown of the neurotransmitter acetylcholine and acts by competitively inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction.
  • Absorption_value0.0
  • Absorption (description)Rapidly absorbed.
  • Caco_2N/A
  • Bioavailability0.0
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life0.5 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityThe estimated minimum lethal dose is 100 mg.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A